Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

315

9:24 Mechanisms Underlying Efficacy of Acetazolamide for Sleep Apnea in Patients With Heart Failure/ S.A. Sands, Boston, MA 9:36 All Apneas and Hypopneas Are Not Created Equal: Event-related Hypoxia Burden Affects Changes in Electroencephalographic Cortical Activity in Obstructive Sleep Apnea Patients/ M. Hajipour, Vancouver, Canada Featured Speaker: 9:48 Unravelling the Pathway Towards Personalized Medicine for Sleep-Disordered Breathing: Novel Insights and Future Directions/ B.A. Edwards, Melbourne, Australia

9:36 A 3D Co-culture System to Gain Insights Into Idiopathic Pulmonary Fibrosis and Perform Drug Screening/ C. Sen, Los Angeles, CA 9:48 Chemokine Receptor 2 Lung Imaging to Monitor Nintedanib Treatment Response in a Fibrosis Model/ H. Farooq, St. Louis, MO

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

D20

MECHANISTIC INSIGHTS IN SLEEP DISORDERED BREATHING

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

8:00 a.m. - 10:00 a.m.

Marriott Marquis Downtown Marquis Ballroom, Salon 6 (Level M2)

Chairing: S. Jelic, New York, NY

D21

TRANSLATIONAL COVID-19 STUDIES

M. Sanchez De La Torre, PhD, Lleida, Spain C. Heiser, MD, Munich, Germany D.C. Lim, MD, Miami, FL R.J. Schwab, MD, Philadelphia, PA

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 206 (Level 2)

Poster Viewing

8:00-8:45 8:45-10:00

Oral Presentations: 8:00 Impact of Continuous Positive Airway Pressure on Serum Angiopoietin-2 Following Coronary Revascularization in Patients With Obstructive Sleep Apnea: The RICCADSA Study/ Y. Celik, Istanbul, Turkey 8:12 Elucidating Influence of Underlying Pulmonary Physiology in the Association of Sleep-Related Hypoxemia and Incident Atrial Fibrillation/ C. Heinzinger, Cleveland, OH 8:24 Associations Among Sleep Apnea, Recurrence of Atrial Fibrillation, and Objective Sleep Duration in Patients Who Underwent Radiofrequency Catheter Ablation for Persistent Atrial Fibrillation/ T. Minami, Kyoto, Japan 8:36 Flow-shape-derived Site of Pharyngeal Collapse Predicts Response to Hypoglossal Nerve Stimulation Therapy/ D. Vena, Boston, MA 8:48 Site of Collapse During Drug-induced Sleep Endoscopy Is Associated With Polysomnographic Endotypes/ S. Op De Beeck, Antwerp, Belgium 9:00 Comparison of Upper Airway Collapse in Drug-induced Sleep Endoscopy and Natural Sleep Endoscopy/ K. Van Den Bossche, Antwerp, Belgium 9:12 Determinants of Transvenous Phrenic Nerve Stimulation-induced Improvements in Left Ventricular Systolic Function in Central Sleep Apnea and Heart Failure/ A. Azarbarzin, Boston, MA

Discussion

Chairing: E.K. Allen, PhD, Memphis, TN

B.D. Kraft, MD, ATSF, FCCP, Saint Louis, MO 701 Longitudinal Evaluation of Blood Cellular Immune Markers and Lung Proteomics in Vaccinated Patients With SARS-CoV-2 Breakthrough Infections/ J.A. Huapaya, Bethesda, MD 702 Respiratory Post Acute COVID-19 Sequelae (PACS)-A Phenotype of Long COVID/ K. Zhang, Hamilton, Canada 703 Fibrinolysis and Inflammation in Convalescent Plasma Treated COVID-19 Patients/ B. Yao, Tyler, TX 704 SARS-CoV-2 Infection in Severe Asthma Is Associated With Worsening of COVID-19 Through Respiratory NLRP3 Inflammasome Activation/ J.S. Jeong, Jeonju, Korea, Republic of 705 Local and Systemic Antibody Response to SARS-CoV-2 Infection in Critically Ill COVID-19 Patients/ C.R. Barnett, New York, NY 706 Meta-analysis of Single-cell RNA-seq Data Reveals Cell-intrinsic and -Extrinsic Dissemination of SARS-CoV-2 Viral RNA: Implications for COVID-19 Pathogenesis/ M.S. Khatun, New Orleans, LA 707 Reduced Antibody and Cell-mediated Immune Responses to SARS-CoV-2 Vaccination in Sarcoidosis/ P.H. Sporn, Chicago, IL 708 Inhaled Statins for the Treatment of COVID-19/ A.A. Zeki, Davis, CA

ATS 2023 • Washington, DC